RS64241B1 - Postupci za dobijanje ćelija izvedenih iz mišića - Google Patents

Postupci za dobijanje ćelija izvedenih iz mišića

Info

Publication number
RS64241B1
RS64241B1 RS20230376A RSP20230376A RS64241B1 RS 64241 B1 RS64241 B1 RS 64241B1 RS 20230376 A RS20230376 A RS 20230376A RS P20230376 A RSP20230376 A RS P20230376A RS 64241 B1 RS64241 B1 RS 64241B1
Authority
RS
Serbia
Prior art keywords
methods
derived cells
muscle derived
obtaining muscle
obtaining
Prior art date
Application number
RS20230376A
Other languages
English (en)
Inventor
Marco Thurner
Eva Margreiter
Wolfgang Schwaiger
Faheem Muhammad Asim
Rainer Marksteiner
Original Assignee
Innovacell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60923243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS64241(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innovacell Ag filed Critical Innovacell Ag
Publication of RS64241B1 publication Critical patent/RS64241B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/71—Oxidoreductases (EC 1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
RS20230376A 2017-12-14 2018-12-14 Postupci za dobijanje ćelija izvedenih iz mišića RS64241B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17207417 2017-12-14
EP18815731.7A EP3724319B1 (en) 2017-12-14 2018-12-14 Methods for obtaining muscle derived cells
PCT/EP2018/085015 WO2019115790A1 (en) 2017-12-14 2018-12-14 Methods for obtaining muscle derived cells

Publications (1)

Publication Number Publication Date
RS64241B1 true RS64241B1 (sr) 2023-06-30

Family

ID=60923243

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20230376A RS64241B1 (sr) 2017-12-14 2018-12-14 Postupci za dobijanje ćelija izvedenih iz mišića

Country Status (24)

Country Link
US (2) US11617768B2 (sr)
EP (2) EP4223872A3 (sr)
JP (2) JP7361398B2 (sr)
KR (1) KR20200099173A (sr)
CN (1) CN111448307A (sr)
AU (1) AU2018383015A1 (sr)
BR (1) BR112020011853A2 (sr)
CA (1) CA3085483A1 (sr)
CL (1) CL2020001480A1 (sr)
CY (1) CY1126049T1 (sr)
DK (1) DK3724319T3 (sr)
ES (1) ES2948712T3 (sr)
FI (1) FI3724319T3 (sr)
HR (1) HRP20230474T1 (sr)
HU (1) HUE062005T2 (sr)
IL (2) IL309687A (sr)
LT (1) LT3724319T (sr)
MX (1) MX2020005881A (sr)
PL (1) PL3724319T3 (sr)
PT (1) PT3724319T (sr)
RS (1) RS64241B1 (sr)
SI (1) SI3724319T1 (sr)
WO (1) WO2019115790A1 (sr)
ZA (1) ZA202002410B (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021065989A1 (ja) * 2019-09-30 2021-04-08 テルモ株式会社 Ｃｄ５６陽性細胞の比率を高めるための方法
EP4380583A1 (en) 2021-08-06 2024-06-12 Innovacell GmbH Myogenic progenitor cells for use in an optimized method for the prevention and treatment of anal incontinence
WO2024115761A1 (en) 2022-12-01 2024-06-06 Universität Zürich Method of preparing a mass culture of muscle precursor cells (mpcs) and uses thereof
WO2024122705A1 (ko) * 2022-12-08 2024-06-13 주식회사 팡세 근육줄기세포의 분화능 예측을 위한 cd56의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
PT1272204E (pt) 2000-04-14 2007-10-02 Univ Pittsburgh Aumento e enchimento de tecidos moles e osso utilizando células progenitoras derivadas de músculo, suas composições e tratamentos
JPWO2003027281A1 (ja) 2001-09-20 2005-01-06 協和醗酵工業株式会社 骨格筋間質由来多分化能幹細胞
EP1617852B1 (en) * 2003-04-25 2010-09-29 The University of Pittsburgh Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration
FR2890977A1 (fr) * 2005-09-19 2007-03-23 Assist Publ Hopitaux De Paris Procede d'obtention de cellules musculaires lisses humaines et leurs applications
WO2007106200A2 (en) * 2006-01-10 2007-09-20 Theradigm, Inc. Expansion and differentiation of neural stem cells under low oxygen conditions
AU2008263134B2 (en) * 2007-05-29 2014-06-19 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
EP2206774A1 (en) 2008-12-23 2010-07-14 Genzyme Corporation Muscle-derived cells having differentiation capacities
CN106350480B (zh) * 2016-08-26 2019-11-08 中国农业科学院北京畜牧兽医研究所 一种纯化牛胎儿骨骼肌组织来源成肌细胞的方法
EP3942020B1 (en) 2019-03-22 2024-05-15 Innovacell GmbH Methods for obtaining induced smooth muscle cells

Also Published As

Publication number Publication date
EP4223872A3 (en) 2023-08-23
US20210069255A1 (en) 2021-03-11
MX2020005881A (es) 2020-08-13
CY1126049T1 (el) 2023-11-15
CA3085483A1 (en) 2019-06-20
IL309687A (en) 2024-02-01
RU2020120580A (ru) 2022-01-14
IL275288A (en) 2020-07-30
EP4223872A2 (en) 2023-08-09
BR112020011853A2 (pt) 2020-11-24
PL3724319T3 (pl) 2023-07-24
JP2023085507A (ja) 2023-06-20
EP3724319B1 (en) 2023-04-05
FI3724319T3 (fi) 2023-05-04
PT3724319T (pt) 2023-06-07
ES2948712T3 (es) 2023-09-18
WO2019115790A1 (en) 2019-06-20
HRP20230474T1 (hr) 2023-07-21
DK3724319T3 (da) 2023-05-01
JP2021506285A (ja) 2021-02-22
KR20200099173A (ko) 2020-08-21
ZA202002410B (en) 2021-09-29
CN111448307A (zh) 2020-07-24
HUE062005T2 (hu) 2023-09-28
CL2020001480A1 (es) 2020-10-30
LT3724319T (lt) 2023-06-12
SI3724319T1 (sl) 2023-07-31
JP7494430B2 (ja) 2024-06-04
US11617768B2 (en) 2023-04-04
EP3724319A1 (en) 2020-10-21
US20230285467A1 (en) 2023-09-14
AU2018383015A1 (en) 2020-05-28
JP7361398B2 (ja) 2023-10-16

Similar Documents

Publication Publication Date Title
SG10201913404YA (en) Solid electrolyte
HK1247992A1 (zh) 高效電池測試器
IL273915A (en) cell
PL3678149T3 (pl) Sposób wytwarzania elektrolitu stałego na bazie lgps
GB201712733D0 (en) Methods & cells
IL275288A (en) Methods for obtaining cells extracted from muscle
GB201707779D0 (en) Cell
GB201707783D0 (en) Cell
GB201707143D0 (en) Method for producing cells
PL3253906T3 (pl) Elektrolit do powlekania elektrolitycznego
GB201720949D0 (en) Cell
GB201718697D0 (en) Cell
GB201502579D0 (en) Cell analysis using dynamic biophysical methods
SG11202000811RA (en) Methods for activating immune cells
GB201703036D0 (en) Methods
IL269849A (en) A method for obtaining differentiated cells from progenitor cells derived from muscle
DK3615520T3 (en) Methods
GB201714718D0 (en) Cell
GB201615741D0 (en) Artificial cells
IL275421A (en) Electrochemical process
HUE056901T2 (hu) Elektrolit lítium-ion akkumulátorokhoz
PT3529262T (pt) Métodos para promover resposta de células t
GB201720343D0 (en) Cell
GB201720344D0 (en) Cell
ZA201708267B (en) Efficient battery tester